Growth Opportunities in the North American Viral Vector and Plasmid DNA Market by 2034 The viral vector and plasmid DNA industry is experiencing significant expansion as advanced biotechnology solutions continue to transform therapeutic development. Growing interest in gene-based treatments, precision medicine, and innovative vaccine platforms is creating strong demand for high-quality manufacturing capabilities across the life sciences sector.
Advancements in cell and gene...